Where does ID Pharma Co., Ltd. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), ID Pharma Co., Ltd. ranks #29,042 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does ID Pharma Co., Ltd. hold?

ID Pharma Co., Ltd. holds 9 US utility patents granted between 2016 and 2025, spanning 4 technology areas.

What is ID Pharma Co., Ltd.'s Innovation Score?

ID Pharma Co., Ltd. has an Innovation Score of 20.1 out of 100 (7th percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is ID Pharma Co., Ltd.'s patent grant rate increasing or decreasing?

ID Pharma Co., Ltd.'s recent grant velocity is +67% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for ID Pharma Co., Ltd.'s patents?

ID Pharma Co., Ltd.'s patents average 8.4 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the ID Pharma Co., Ltd. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

ID Pharma Co., Ltd.

Q: What technology areas does ID Pharma Co., Ltd. focus on?

ID Pharma Co., Ltd.'s top technology area is C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media) with 9 patents, ranking #1,126 of 4,144 assignees active in that subclass. Grants appear in 4 CPC subclasses total.

USPTO PatentsView assignee record - 9 granted patents across 4 technology areas, recorded in grant years 2016–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, ID ranks #29,042 of 49,997 tracked US assignees by granted-patent volume, with 9 patents across 4 technology areas.

#29,042
of 49,997 US assignees by volume: 7th percentile
by Innovation Score (20.1/100): 8.4
avg claims per patent: +67%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R29042 · Foreign Corporation #29,042 · 9 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-PAR · TYPE-FRNCORP · VEL-SURGE · BOOK-FULL

GRANTS-MICRO 9 grants
MID-PACK #29,042/49,997
PHOTO-FINISH Icare Finland OY
CPC-NARROW C12N · 4 areas
INNOV-THIN 20.1/100
CLAIMS-PAR 8.4 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-SURGE +67% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Icare Finland OY (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How ID’s 20.1 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 8.0 pts (40%) Velocity 0.0 pts (0%) Breadth 7.1 pts (35%) Claim depth 5.1 pts (25%)

Qualcomm Incorporated · highest

85
Gibraltar · near

20
Midwest Can · near

20
ID Pharma · this assignee

20
Seahorse Bioscience · near

20
NeuroEnterprises · near

20
3D Lighting… · lowest

7

What this shows ID's Innovation Score is 20.1/100 (7th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for ID?

Each dot is one of ID’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). ID’s own 8.4 claims/patent is at or below the 11.1 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

ID vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where ID's grants concentrate

ID Pharma Co., Ltd. is a focused PatentsView assignee: 4 CPC subclasses with 100% of grants classified under C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media). Peak complete grant year is 2021 (3 grants) versus a trough of 1 in 2016. By volume, ID sits between Icare Finland OY and IGM Resins Italia S.R.L..

Icare Finland OY

9
ICG Licensing

9
Icon Bioscience

9
Icos

9
IDM Global

9
Idsc Holdings

9
Ifco Systems

9
IGM Resins Italia…

9
ID Pharma ◀

9

What this shows ID holds 9 patents at rank #29,026, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near ID

By rank, the assignees closest to #29,026 in granted patent volume.

Leaders in C12N (Microorganisms OR Enzymes)

Other assignees with the most granted patents in ID's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for ID, neither rank-band nor same-CPC leaders (those blocks stay above). In C12N (Microorganisms OR Enzymes), ID ranks #1,126 of 4,144 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (20 here).

Seahorse Bioscience 20 NeuroEnterprises, LLC 20 Gibraltar, Inc. 20 Midwest Can Company, LLC 20

ID's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

20 7th percentile higher than 7% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2016–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.

View data table

ID Pharma Co., Ltd. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2016	1	11.1%
2017	1	11.1%
2018	1	11.1%
2020	2	22.2%
2021	3	33.3%
2025partial year	1	11.1%

Which technologies does ID Pharma Co., Ltd. patent most?

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 9

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 7

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 6

C07K - Peptides 4

Top 4 of 4 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

ID Pharma Co., Ltd.'s patent record in context - here's where to go next.

ID Pharma Co., Ltd.'s lead technology class is C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media), 100% of its portfolio - see every assignee active in that class. Explore C12N
Ranked #29,042 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare ID Pharma Co., Ltd. against Icare Finland OY, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 20.1/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent , US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.